Skip to content
value.today
Total raised
$159 M
5 rounds on record
Latest round
$17 M
Jul 2015
First round on record
Apr 2014
Today
Went public
See the company page

Conkwest, Inc. is listed today as ImmunityBio, Inc.: market value, financials and filings are on its company page.

Funding rounds

5 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Conkwest, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2023$470 MPrivate placement after listing$250 million to $1 billion

Conkwest, Inc.: Private sale, Sep 2023

Investors in this round

3 investors had bought by the notice of Sep 22, 2023: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$470 M of $470 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Sachs · Executive Officer
  • Patrick Soon-Shiong · Executive Officer, Director
  • Richard Adcock · Executive Officer, Director
  • Barry Simon · Director
  • Cheryl Cohen · Director
  • Christobel Selecky · Director
  • John Brennan · Director
  • Linda Maxwell · Director
  • Michael Blaszyk · Director
  • Wesley Clark · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “Nant Capital, LLC received an origination fee of $1 mil in connection with the issuance of the $200 mil convertible promissory note.”
  • On the amounts: “Exchange of $269,986,600 in convertible notes for common stock; issuance of $200 mil convertible note”

Signed by David Sachs, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 22, 2023. Read the notice at the SEC.

equity, debtSEC
Jul 2022$11 MPrivate placement after listing$10 to $50 million

Conkwest, Inc.: Private sale, Jul 2022

Investors in this round

6 investors had bought by the notice of Jul 22, 2022: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Sachs · Executive Officer
  • Patrick Soon-Shiong · Executive Officer, Director
  • Richard Adcock · Executive Officer, Director
  • Barry Simon · Director
  • Cheryl Cohen · Director
  • Christobel Selecky · Director
  • John Brennan · Director
  • Linda Maxwell · Director
  • Michael Blaszyk · Director
  • Wesley Clark · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Shares of common stock of the company issued with an aggregate value of $10,656,035 on the issuance date in connection with settlement of litigation matter.”

Signed by David Sachs, Chief financial officer. Source: SEC Form D, newest notice filed Jul 22, 2022. Read the notice at the SEC.

equitySEC
Jul 2015$17 MNo. 5$10 to $50 million

Conkwest, Inc.: Raise no. 5, Jul 2015

Investors in this round

1 investor had bought by the notice of Aug 5, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry J. Simon, M.D. · Executive Officer, Director
  • Patrick Soon-Shiong, M.D. · Executive Officer, Director
  • Richard J. Gomberg · Executive Officer
  • Henry J. Ji, Ph.D. · Director
  • John C. Thomas, Jr. · Director
  • John T. Potts, Jr., M.D. · Director
  • Michael C. Blaszyk · Director
  • Richard J. Kusserow · Director
  • Robert T. Rosen · Director
  • Steve J. Gorlin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Gomberg, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 5, 2015. Read the notice at the SEC.

equitySEC
Jun 2015$78 MNo. 4$50 to $250 million

Conkwest, Inc.: Raise no. 4, Jun 2015

Investors in this round

11 investors had bought by the notice of Jul 17, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$78 M of $78 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry J. Simon, M.D. · Executive Officer, Director
  • Patrick Soon-Shiong, M.D. · Executive Officer, Director
  • Richard J. Gomberg · Executive Officer
  • Hans C. Klingemann, M.D., Ph.D. · Director
  • Henry J. Ji, Ph.D. · Director
  • John C. Thomas, Jr. · Director
  • John T. Potts, Jr., M.D. · Director
  • Richard J. Kusserow · Director
  • Robert T. Rosen · Director
  • Steve J. Gorlin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Gomberg, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 17, 2015. Read the notice at the SEC.

equitySEC
Dec 2014$48 MNo. 3$10 to $50 million

Conkwest, Inc.: Raise no. 3, Dec 2014

Investors in this round

1 investor had bought by the notice of Jan 5, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$48 M of $48 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Simon · Executive Officer, Director
  • Richard Gomberg · Executive Officer
  • Hans G. Klingemann · Director
  • Henry G. Ji · Director
  • John G. Potts · Director
  • John G. Thomas · Director
  • Patrick G. Soon-Shiong · Director
  • Richard G. Kusserow · Director
  • Robert G. Rosen · Director
  • Steven Gorlin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Gomberg, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 5, 2015. Read the notice at the SEC.

equitySEC
Dec 2014$10 MNo. 2$10 to $50 million

Conkwest, Inc.: Raise no. 2, Dec 2014

Investors in this round

1 investor had bought by the notice of Dec 29, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Simon · Executive Officer, Director
  • Richard Gomberg · Executive Officer
  • Hans G. Klingemann · Director
  • Henry G. Ji · Director
  • John G. Potts · Director
  • John G. Thomas · Director
  • Patrick G. Soon-Shiong · Director
  • Richard G. Kusserow · Director
  • Robert G. Rosen · Director
  • Steven Gorlin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Gomberg, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 29, 2014. Read the notice at the SEC.

equitySEC
Apr 2014$7 MNo. 1$2 to $10 million

Conkwest, Inc.: Raise no. 1, Apr 2014

Investors in this round

48 investors had bought by the notice of Apr 17, 2014: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$518,748
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Simon · Executive Officer, Director
  • Hans Klingemann · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Palladium Capital Advisors, LLC (CRD 129400) · New York, New YorkSold in AZ, CA, DC, FL, GA, IL, MA, NJ, NY, TN, TX, WA

Remarks in the notice

  • On the use of proceeds: “While no proceeds are to be paid to any of the named persons, a portion of the proceeds of the offering may be used for working capital which may include the payment of accrued salaries or other obligations owed to Dr. Barry Simon.”

Signed by Barry Simon, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Apr 17, 2014. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company ImmunityBio, Inc., its revenue in fiscal 2025 came from these product and service lines: Other revenues $310,000 (0%).

    Annual report (SEC XBRL) · Dec 2025

  • Conkwest, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).

    SEC Form D · Sep 2023

  • Revenue range over time, as stated in its notices: revenue between $5 million and $25 million in 2014; revenue of up to $1 million in 2015.

    SEC Form D (revenue range) · Jan 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2023

Products and services#

No products or services of Conkwest, Inc. are on record.

Investors#

No investor of Conkwest, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 48 investors.

Largest shareholders today

Institutions holding ImmunityBio, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conkwest, Inc.
NameRoleNamed in
David SachsExecutive officerSep 2023
Patrick Soon-ShiongExecutive officerSep 2023
Richard AdcockExecutive officerSep 2023
Barry J. Simon, M.D.Executive officerAug 2015
Patrick Soon-Shiong, M.D.Executive officerAug 2015
Richard J. GombergExecutive officerAug 2015
Barry SimonExecutive officerJan 2015
Richard GombergExecutive officerJan 2015
Barry SimonDirectorSep 2023
Cheryl CohenDirectorSep 2023
Christobel SeleckyDirectorSep 2023
John BrennanDirectorSep 2023
Linda MaxwellDirectorSep 2023
Michael BlaszykDirectorSep 2023
Patrick Soon-ShiongDirectorSep 2023
Richard AdcockDirectorSep 2023
Wesley ClarkDirectorSep 2023
Barry J. Simon, M.D.DirectorAug 2015
Henry J. Ji, Ph.D.DirectorAug 2015
John C. Thomas, Jr.DirectorAug 2015
John T. Potts, Jr., M.D.DirectorAug 2015
Michael C. BlaszykDirectorAug 2015
Patrick Soon-Shiong, M.D.DirectorAug 2015
Richard J. KusserowDirectorAug 2015
Robert T. RosenDirectorAug 2015
Steve J. GorlinDirectorAug 2015
Hans C. Klingemann, M.D., Ph.D.DirectorJul 2015
Hans G. KlingemannDirectorJan 2015
Henry G. JiDirectorJan 2015
John G. PottsDirectorJan 2015
John G. ThomasDirectorJan 2015
Patrick G. Soon-ShiongDirectorJan 2015
Richard G. KusserowDirectorJan 2015
Robert G. RosenDirectorJan 2015
Steven GorlinDirectorJan 2015
Hans KlingemannDirectorApr 2014

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.